Kavita M. Dhodapkar

As a dedicated researcher at Emory University, Kavita M. Dhodapkar has developed a specialized expertise in immunotherapy, CAR-T cell therapy, multiple myeloma, immune responses, cancer immunology, hematologic malignancies, tumor microenvironment, vaccine responses. A representative example of their recent contribution is the study titled "Regulation of antigen-specific T cell infiltration and spatial architecture in multiple myeloma and premalignancy", which offers critical insights into the dynamics of immunotherapy and CAR-T cell therapy. Additional work such as "Clinical response and pathway-specific correlates following TIGIT–LAG3 blockade in myeloma: the MyCheckpoint randomized clinical trial" further demonstrates their commitment to advancing knowledge in this domain.